Official registry condition

Renal Impairment peptide trials

4 selected ClinicalTrials.gov records carrying the official condition label Renal Impairment. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

4 selected records.

Connected peptides

4 profiles.

Registry update years

2012–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases1

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses2

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 28 selected PubMed records and 1 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Renal Impairment unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT04178447

PeptideScanner retained ClinicalTrials.gov record NCT04178447 at 2026-11-16T01:46:56.290Z. Its registry update date was 2020-11-18, and PeptideScanner's reviewed identity mapping was glepaglutide.

PeptideScanner change date
November 16, 2026
Cited source date
November 18, 2020
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT07426380

PeptideScanner retained ClinicalTrials.gov record NCT07426380 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-08-19, and PeptideScanner's reviewed identity mapping was eloralintide.

PeptideScanner change date
November 16, 2026
Cited source date
August 19, 2026
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01028768

PeptideScanner retained ClinicalTrials.gov record NCT01028768 at 2026-11-15T21:55:23.600Z. Its registry update date was 2012-05-07, and PeptideScanner's reviewed identity mapping was teduglutide.

PeptideScanner change date
November 15, 2026
Cited source date
May 7, 2012
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →